Topical Mitomycin C is indicated in the treatment of which of the follwoing conditions?
Topical application of Mitomycin C after endoscopic dilatation of laryngotracheal stenosis prevents restenosis. Mitomycin-C (MMC) inhibits fibroblast proliferation and synthesis of extracellular matrix proteins, and thereby modulates wound healing and scarring.
Endoscopic treatment of angiofibroma
Treatment of skull base osteomyelitis
Sturge Weber syndrome
Treatment for laryngeal stenosis